BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38340584)

  • 21. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.
    Zell M; Assal A; Derman O; Kornblum N; Battini R; Wang Y; Narasimhulu DM; Mantzaris I; Shastri A; Verma A; Ye H; Braunschweig I; Janakiram M
    Oncotarget; 2016 Aug; 7(32):51981-51990. PubMed ID: 27341021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
    Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
    J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
    Yoshimitsu M; White Y; Arima N
    Recent Results Cancer Res; 2014; 193():211-25. PubMed ID: 24008301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan.
    Yamada Y; Tomonaga M
    Leuk Lymphoma; 2003 Apr; 44(4):611-8. PubMed ID: 12769337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
    Motohashi K; Suzuki T; Kishimoto K; Numata A; Nakajima Y; Tachibana T; Ohshima R; Kuwabara H; Tanaka M; Tomita N; Ishigatsubo Y; Fujisawa S
    Int J Hematol; 2013 Aug; 98(2):258-60. PubMed ID: 23801427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
    Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.
    Morishige S; Nishi M; Saruta H; Arakawa F; Yamasaki Y; Oya S; Nakamura T; Seki R; Yamaguchi M; Aoyama K; Mouri F; Osaki K; Ohshima K; Nagafuji K
    Int J Hematol; 2019 Oct; 110(4):506-511. PubMed ID: 31152415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
    Nakahata S; Morishita K
    J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
    Shafiee A; Seighali N; Taherzadeh-Ghahfarokhi N; Mardi S; Shojaeian S; Shadabi S; Hasani M; Haghi S; Mozhgani SH
    Virol J; 2023 Jun; 20(1):118. PubMed ID: 37287047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
    Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
    J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult T-cell leukemia/lymphoma with multiple integration of HTLV-1 provirus presenting as an isolated paranasal sinus tumor: a case report.
    Nagasaki A; Miyagi T; Taira T; Shinhama A; Kojya S; Suzuki M; Aonahata M; Yoshimi N; Takasu N
    Head Neck; 2008 Jun; 30(6):815-20. PubMed ID: 18023035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.
    de Mendoza C; Rando A; Miró E; Pena MJ; Rodríguez-Avial I; Ortega D; González-Praetorius A; Reina G; Pintos I; Pozuelo MJ; Soriano V;
    J Clin Virol; 2023 Oct; 167():105578. PubMed ID: 37660433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
    Kozako T; Yoshimitsu M; Fujiwara H; Masamoto I; Horai S; White Y; Akimoto M; Suzuki S; Matsushita K; Uozumi K; Tei C; Arima N
    Leukemia; 2009 Feb; 23(2):375-82. PubMed ID: 18830259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
    Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
    Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.
    Banerjee P; Tripp A; Lairmore MD; Crawford L; Sieburg M; Ramos JC; Harrington W; Beilke MA; Feuer G
    Blood; 2010 Apr; 115(13):2640-8. PubMed ID: 20124219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma.
    Fukushima T; Miyazaki Y; Honda S; Kawano F; Moriuchi Y; Masuda M; Tanosaki R; Utsunomiya A; Uike N; Yoshida S; Okamura J; Tomonaga M
    Leukemia; 2005 May; 19(5):829-34. PubMed ID: 15744352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.
    Jo T; Kubota-Koketsu R; Kaneko Y; Sakai T; Noguchi K; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Immunol Immunother; 2023 Apr; 72(4):929-944. PubMed ID: 36181532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers.
    Kondo H; Soda M; Sawada N; Inoue M; Imaizumi Y; Miyazaki Y; Iwanaga M; Tanaka Y; Mizokami M; Tsugane S
    Cancer Causes Control; 2016 Sep; 27(9):1059-66. PubMed ID: 27412633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
    Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y
    Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult T-cell leukemia/lymphoma in a Peruvian hospital in human T-lymphotropic virus type 1 (HTLV-1) positive patients.
    Rodríguez-Zúñiga MJ; Cortez-Franco F; Qujiano-Gomero E
    Int J Dermatol; 2017 May; 56(5):503-509. PubMed ID: 28251608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.